IXICO has supported important Alzheimer's Disease research since 2007. We have provided imaging biomarkers for over 70 clinical studies in neuroscience, of which, over 30 have been in Alzheimer's disease.
Read moreIXICO first supported a clinical study for PD in 2016 and continue to invest in our technological solutions to support clinical trials in this area.
Read moreWe are a trusted imaging provider and preferred supplier for pharma and biotech, with IXICO providing advanced imaging analytics for 11 HD trials.
Read moreWe have been involved in MS since 2015 through our Assessa PML collaboration with big pharma.
Read moreIXICO has supported clinical trials in this area since 2015 having provided advanced analytics for 5 clinical trials across 230 global sites.
Read moreIXICO specialises in imaging operations, data managment and analytics of rare neurological disorders, including but not limited to Huntington's Disease (HD), Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), and Spinocerebellar Ataxia (SCA).
Read more